InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-3.5%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Grove Robert Earle, Director. Director active across 1 company, notably IRIDEX CORP. Aggregated, 6 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €18k. History available since 16 June 2021. The latest transaction was disclosed on 14 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
39,267 shares@ US$1.9179.7% of flowCommon StockSEC:0001209191-23-037565:0
27,472 shares0Common StockSEC:0001209191-22-037550:0
1,644 shares@ US$6.0820.050% mcap50.0% of flowCommon StockSEC:0001209191-21-067672:0
Ideal exit: 29 Aug 2022 (T+270)
1,644 shares@ US$6.08210.2% of flowCommon StockSEC:0001209191-21-067672
Ideal exit: 29 Aug 2022 (T+270)
5,420 shares0Common StockSEC:0001209191-21-042265:0
5,420 shares0Common StockSEC:0001209191-21-042265
6 of 6 declarations
About Grove Robert Earle
Grove Robert Earle is a Board Member at IRIDEX CORP. He brings valuable expertise in the medical field, contributing to the strategic direction of the company. His role includes overseeing operations and commitment to best governance practices.
